Eastman 3rd Quarter 2026 Sales and Earnings Results Conference Call - EASTMAN CHEMICAL CO

Financial Performance:

• Full-year 2026 adjusted operating cash flow guidance lowered from $900M to $850M due to working capital buildup (approx. $560M YTD) driven by inflationary pressures and inventory accumulation for supply security.
• Advanced Materials segment faces a full-year $30M headwind from price-cost spreads (half in Q4), driven by high PX costs from the Iran conflict and locked-in film pricing; Q3 saw a $15M headwind specifically.
• Chemical Intermediates (CI) earnings in Q4 are impacted by an unusual $20/lb propylene arbitrage between Asia and the US, though a return to historical spreads is expected in 2027.
• Acetate segment earnings are expected to remain stable in 2027 despite mid-single-digit price declines, supported by anticipated volume recovery and improved asset utilization.
• Inventories are estimated to be up $250M YoY; days inventory decreased from 115 to 105 days from year-end 2025 to Q3 2026, with a projected release tailwind in 2027.
• Circular business is on track to generate ~$20M in incremental earnings on $100M in revenue for 2026.

Guidance and Future Outlook:

• Circular economy revenue is projected to reach $100M+ in 2026, with significant growth expected in 2027 as new rPET capacity comes online; 2027 guidance is conservative pending economic clarity.
• Volume mix growth of 3% is expected for Advanced Materials in 2026; full-year 2027 volume growth is anticipated across Advanced Materials, AFP, and Fibers.
• 2027 capital expenditure (CapEx) is expected to be around $500M (baseline), up from ~$400M in 2026, largely driven by the first phase of the Kingsport methanolysis expansion and the Metathesis project.
• Cash flow is projected to exceed $850M in 2027 as working capital normalizes, assuming no further escalation in geopolitical conflicts.
• Management expects Q4 to be a difficult proxy for 2027 due to seasonal lows and temporary arbitrage distortions; Q3 performance is viewed as a more stable baseline.

Business Segments and Product Lines:

• Advanced Materials: Growth driven by innovation in EV/ICE interlayers (HUD applications) and the "Triton" circular solution; impacted by China's ~20% market decline but stabilized by broadening mid-tier positioning.
• Circular Solutions: Q3 saw operational delays with the Triton line and polymer line conversion (due to bad pumps and startup issues), which impacted Q3 volume but are fully resolved for Q4; the converted line will be available for full-year 2027 production.
• Acetate: Low-cost leader position maintained; market share recovery in 2027 expected as competitors destock and new contract cycles open; recent Genon/Clariant combination in Europe viewed as potentially stabilizing.
• Metathesis (E2P) Project: Re-emerging as a priority investment to replace ethylene volatility; expected to add ~$100M in average earnings with a 1–2 year payback; target online date is mid-2028.

Market and Competitive Landscape:

• Geopolitics: The Iran conflict has created sustained high raw material costs and supply chain volatility, disrupting expected Q4 tailwinds; resolution of the conflict is seen as a potential major stimulus for consumer confidence.
• China: Advanced Materials performance heavily impacted by a ~20% decline in Chinese sales demand; Fibers and Acetate also facing challenges with low inventory levels and contract renewals.
• Competition: No material capacity expansions expected from Japanese competitors in interlayers; Acetate competitors are facing high-cost structures post-acquisition.
• Market Dynamics: Markets described as "stagflationary" since 2022; consumer resilience noted despite affordability issues; significant pent-up demand exists post-2020.

Risks and Challenges:

• Input Costs: Persistent inflation in raw materials (PX, oil) due to geopolitical tensions creating headwinds for Q4 earnings.
• Operational Delays: Specific startup delays at the Triton line and polymer conversion impacted Q3 volume and added expenses.
• Inventory: High inventory levels of raw materials (PX) and finished goods create working capital pressure to be released in Q4/2027.
• Market Volatility: The unique propylene arbitrage between Asia and the US creates short-term earnings uncertainty, though expected to normalize quickly.

Management Commentary and Tone:

• Tone: Management expressed high confidence in the DOE grant and the strategic pivot to circular economy, while maintaining a realistic view of short-term macro headwinds.
• Confidence: Strong belief in the ability to recover margins via Jan 1 price increases and to stabilize Acetate earnings in 2027 despite price declines.
• Capital Discipline: Emphasis on "responsible capital allocation," prioritizing circular growth projects over other organic investments until the macro environment stabilizes.
• Grant Reaction: Expressed excitement over the reinstated DOE grant, viewing it as a catalyst for US supply chain resiliency and reduced CapEx burden.

Analyst Questions and Answers:

• DOE Grant Allocation: Confirmed grant covers 30–50% of CapEx for the Kingsport expansion, including debottlenecking the first plant and building the second; scope reduced by utilizing existing shutdown assets (polymer lines, infrastructure).
• Volume Growth Drivers: Q4 volume growth confidence stems from the "Triton" momentum, innovation in consumer durables, and stabilized market presence in performance films.
• 2027 Earnings Outlook: Metathesis project could have added ~$100M to 2026 earnings if online; 2027 earnings stability expected from volume growth in Acetate and Circular, offsetting price declines.
• Inventory Management: Inventory reduction will occur naturally through Q4 turnarounds and 2027 volume growth; no need to cut operating rates.
• CapEx Specifics: 2027 CapEx baseline estimated at $500M; the DOE grant effectively covers ~50% of the incremental spend for the first phase of the circular expansion.

Other Key Points:

• The "Triton" circular technology is central to the company's strategy to win market share against traditional materials in packaging and durables.
• Management highlighted that the first plant build provided learnings that will significantly reduce the CapEx and cost per ton for the second plant.
• The company is shifting focus to exporting olefin derivatives to Europe to offset the domestic propylene arbitrage disadvantage.
• The Iran conflict has forced a shift in raw material purchasing strategy to prioritize security of supply over just cost minimization.